Review about Ginkgo biloba special extract EGb 761 (Ginkgo)

Current Pharmaceutical Design

Volumn 10, Issue 3, 2004, Pages 261-264

  Gertz, H J ^a   Kiefer, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDROERGOTOXINE; FLAVONOID; GINKGO BILOBA EXTRACT; NIMODIPINE; PIRACETAM; TERPENOID; WARFARIN;

ALZHEIMER DISEASE; BLEEDING; CLINICAL TRIAL; COGNITION; DAILY LIFE ACTIVITY; DEMENTIA; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; MEMORY DISORDER; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RATING SCALE; RETINA MACULA DEGENERATION; REVIEW; SCORING SYSTEM; SEASONAL AFFECTIVE DISORDER; TINNITUS;

ALZHEIMER DISEASE; CLINICAL TRIALS; GINKGO BILOBA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 0347917012     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043386437     Document Type: Review

References (22)

1. Amaducci L, Angst J, Bech P, Benkert O, Bruinvels J, Engel RR, et al. Pharmacopsychiatry 1990; 23: 171-5.
2. Dahlke F, Lohaus A, Gutzmann H. Psychopharmacol Bull 1992; 28 425-32.
3. Del Tredici P. Arnoldia 1993; 53: 25-9.
4. Drew S, Davies E. BMJ 2001; 322: 73.
5. Foster S, Chongxi Y. Healing Arts Press: Rochester Vermont 1992.
6. Goepel B. Mitteilungen aus Forschung und Praxis 1965; 4: 10-1.
7. Hofferberth B. Human Psychopharmacol 1994; 9: 215-22.
8. Kanowski S, Ladurner G, Maurer K, Oswald WD, Stein U. In Alzheimer's disease epidemiology neuropathology neurochemistry and clinics Maurer K. Riederer P. Beckmann H. Eds. Springer-Verlag: Wien - New York 1990; pp. 531-43.
9. Kanowski S, Hermann WM, Stephan K, Wierich W, Hörr R. Pharmacopsychiatry 1996; 29: 47-56.
10. Kuhn E. Mitteilungen aus Forschung und Praxis 1965; 4: 8-9.
11. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. JAMA 1997; 278: 1327-32.
12. Le Bars PL, Kieser M, Itil KZ. Dement Geriatr Cogn Disord 2000; 11: 230-7.
13. Lingaerde O, Foreland AR, Magnusson A. Acta Psychiatr Scand 1999; 100: 62-6.
14. Mayeux R, Sano M. N Engl J Med 1999; 341: 1670-9.
15. Oken BS, Storzbach DM, Kaye JA. Arch Neurol 1998; 55: 1409-15.
16. Stoppe G, Sandholzer H, Staedt J, Winter S, Kiefer J, Ruther E. Pharmacopsychiatry 1996; 29: 150-5.
17. Trunzler G, Gäbler H. Mitteilungen aus Forschung und Praxis 1965; 4: 3-7.
18. van Dongen MC, van Rossum E, Kessels AG, Sielhorst H. J, Knipschild PG. J Am Geriatr Soc 2000; 48: 1183-94.
19. Wesnes K, Simmons D, Rook M, Simpson P. Human Psychopharmacology 1987; 2: 159-96.
20. Alarcon de la Lastra C, Barranco M. D, Motilva V, Herrerias J. M. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Design 2001; 7(10): 933-50.
21. Croft S. L. and Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Design 2002; 8(4): 319-42.
22. Fahy J, and Hill B. T. Tubulin-interacting agents. Epilogue. Curr Pharm Design 2001; 7(13): 1297-301.